Anavex Life Sciences Corp (AVXL)

[attilathehunt]

“I agree. I am in the camp that they must have scene something to go into the pediatric market for Rhett.”

Or perhaps, they didn’t see anything special and now moving upstream to ascertain if A2-73 works at an earlier onset. One never knows what TGD is thinking except for maintaining a 2 year cash position. I suspect we will hear of a larger dilution before end of year since no top line data will be available. I expect the dilution PR to follow full enrollment PR. Hang on for the ride.